advertisement

---

Yoshii K 11

Showing records 1 to 11 | Display all abstracts from Yoshii K

86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Maruyama Y
British Journal of Ophthalmology 2021; 105: 169-173

---

86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Maruyama Y; Ikeda Y
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233

---

86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Ikeda Y; Mori K
British Journal of Ophthalmology 2021; 105: 169-173

---

86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Mori K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233

---

86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshii K
British Journal of Ophthalmology 2021; 105: 169-173

---

86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Yoshii K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233

---

86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Ueno M
British Journal of Ophthalmology 2021; 105: 169-173

---

86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Ueno M; Sotozono C
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233

---

86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Yoshikawa H; Sotozono C
British Journal of Ophthalmology 2021; 105: 169-173

---

86452 Safety and Efficacy of Long-Term Ripasudil 0.4% Instillation for the Reduction of Intraocular Pressure in Japanese Open-Angle Glaucoma Patients
Kinoshita S
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 229-233

---

86655 Morphological change and recovery of corneal endothelial cells after rho-associated protein kinase inhibitor eye-drop (ripasudil 0.4%) instillation
Kinoshita S
British Journal of Ophthalmology 2021; 105: 169-173

---